KEGG   PATHWAY: lve05416
Entry
lve05416                    Pathway                                
Name
Viral myocarditis - Lipotes vexillifer (Yangtze River dolphin)
Description
Myocarditis is a cardiac disease associated with inflammation and injury of the myocardium. It results from various etiologies, both noninfectious and infectious, but coxsackievirus B3 (CVB3) is still considered the dominant etiological agent. Myocarditis may be caused by direct cytopathic effects of virus, a pathologic immune response to persistent virus, or autoimmunity triggered by the viral infection. The virus enters the myocyte through internalization of the coxsackie-adenoviral receptor (CAR) and its coreceptor, decay-accelerating factor (DAF). Viral proteases cleave various proteins in the host cell. One example is viral protease 2A, which cleaves eukaryote initiation factor 4G (eIF4G) and the dystrophin protein, resulting in a complete shutdown of cap-dependent RNA translation and cytoskeletal destruction in infected cardiomyocytes, respectively. CVB3 also cleaves the member of the Bcl-2 family Bid, leading to apoptosis. CVB3 infection also induces the cleavage of cyclin D protein through a proteasome-dependent pathway, leading to the host cell-growth arrest. Viral infection and necrosis of myocytes may lead to the release of intracellular antigens, resulting in activation of self-reactive T cells. CVB infection is a significant cause of dilated cardiomyopathy (DCM) as well as myocarditis. Epidemiologically, myocarditis underlies a significant portion of patients with DCM.
Class
Human Diseases; Cardiovascular disease
Pathway map
lve05416  Viral myocarditis
lve05416

Disease
H00295  Viral myocarditis
Organism
Lipotes vexillifer (Yangtze River dolphin) [GN:lve]
Gene
103068685  CD86; T-lymphocyte activation antigen CD86 isoform X1 [KO:K05413]
103069156  [KO:K08738]
103069270  DTNA; dystrobrevin alpha isoform X1 [KO:K26998]
103070177  CD40LG; CD40 ligand isoform X1 [KO:K03161]
103070352  SGCE; epsilon-sarcoglycan isoform X1 [KO:K27061]
103071468  CD28; T-cell-specific surface glycoprotein CD28 [KO:K06470]
103071514  SNTA1; alpha-1-syntrophin isoform X1 [KO:K24063]
103071515  CD40; tumor necrosis factor receptor superfamily member 5 [KO:K03160]
103071829  FYN; tyrosine-protein kinase Fyn isoform X1 [KO:K05703] [EC:2.7.10.2]
103072242  SGCA; alpha-sarcoglycan [KO:K12565]
103072657  [KO:K06788]
103073819  CASP3; caspase-3 [KO:K02187] [EC:3.4.22.56]
103074484  SNTB1; beta-1-syntrophin [KO:K24064]
103074749  RAC1; ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392]
103074768  EIF4G2; eukaryotic translation initiation factor 4 gamma 2 [KO:K03260]
103074980  SGCD; delta-sarcoglycan-like [KO:K12563]
103075075  [KO:K06856]
103075361  [KO:K06856]
103075495  [KO:K08738]
103076172  ABL1; tyrosine-protein kinase ABL1 [KO:K06619] [EC:2.7.10.2]
103076235  [KO:K06751]
103076541  RAC2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
103076813  PRF1; perforin-1 [KO:K07818]
103077054  CASP8; caspase-8 [KO:K04398] [EC:3.4.22.61]
103077123  DAG1; dystroglycan isoform X1 [KO:K06265]
103077223  ACTB; actin, cytoplasmic 1 [KO:K05692]
103077688  SNTB2; beta-2-syntrophin [KO:K24064]
103078413  SSPN; sarcospan [KO:K22194]
103078531  BID; BH3-interacting domain death agonist [KO:K04726]
103078532  LAMA2; laminin subunit alpha-2 isoform X1 [KO:K05637]
103079514  RAC3; ras-related C3 botulinum toxin substrate 3 [KO:K07861]
103079638  [KO:K08738]
103079699  ICAM1; intercellular adhesion molecule 1 [KO:K06490]
103079755  ITGB2; integrin beta-2 [KO:K06464]
103079814  ABL2; Abelson tyrosine-protein kinase 2 [KO:K08887] [EC:2.7.10.2]
103079859  SGCB; beta-sarcoglycan [KO:K12566]
103080113  CD55; complement decay-accelerating factor [KO:K04006]
103081594  LAMA1; laminin subunit alpha-1 [KO:K05637]
103082615  CAV3; caveolin-3 [KO:K12959]
103083060  [KO:K06751]
103083173  [KO:K08738]
103083691  [KO:K06752]
103085165  [KO:K06751]
103085172  [KO:K06752]
103085441  [KO:K06752]
103085864  SGCZ; zeta-sarcoglycan [KO:K27062]
103085940  CD80; T-lymphocyte activation antigen CD80 isoform X1 [KO:K05412]
103086000  [KO:K06752]
103086254  ITGAL; integrin alpha-L isoform X1 [KO:K05718]
103086318  EIF4G1; eukaryotic translation initiation factor 4 gamma 1 isoform X1 [KO:K03260]
103086365  DMD; dystrophin [KO:K10366]
103086383  ACTG1; actin, cytoplasmic 2 [KO:K05692]
103086530  SGCG; gamma-sarcoglycan [KO:K12564]
103086745  CASP9; caspase-9 isoform X1 [KO:K04399] [EC:3.4.22.62]
103086796  [KO:K06752]
103086977  [KO:K06751]
103087297  [KO:K06752]
103087452  [KO:K06752]
103087567  [KO:K06752]
103090138  NOS1; nitric oxide synthase, brain [KO:K13240] [EC:1.14.13.39]
103090453  MYH7; myosin-7 [KO:K17751]
103090612  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
103090716  MYH6; myosin-6 [KO:K17751]
103091453  CAV1; caveolin-1 isoform X1 [KO:K06278]
Reference
  Authors
Esfandiarei M, McManus BM
  Title
Molecular biology and pathogenesis of viral myocarditis.
  Journal
Annu Rev Pathol 3:127-55 (2008)
DOI:10.1146/annurev.pathmechdis.3.121806.151534
Reference
  Authors
Badorff C, Knowlton KU
  Title
Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside.
  Journal
Med Microbiol Immunol 193:121-6 (2004)
DOI:10.1007/s00430-003-0189-7
Reference
  Authors
Maekawa Y, Ouzounian M, Opavsky MA, Liu PP
  Title
Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity.
  Journal
Circulation 115:5-8 (2007)
DOI:10.1161/CIRCULATIONAHA.106.670554
Reference
  Authors
Pankuweit S, Portig I, Maisch B
  Title
Pathophysiology of cardiac inflammation: molecular mechanisms.
  Journal
Herz 27:669-76 (2002)
DOI:10.1007/s00059-002-2421-4
Reference
  Authors
Gao G, Luo H
  Title
The ubiquitin-proteasome pathway in viral infections.
  Journal
Can J Physiol Pharmacol 84:5-14 (2006)
DOI:10.1139/y05-144
Reference
  Authors
Coyne CB, Bergelson JM
  Title
Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions.
  Journal
Cell 124:119-31 (2006)
DOI:10.1016/j.cell.2005.10.035
Reference
  Authors
Badorff C, Lee GH, Knowlton KU
  Title
Enteroviral cardiomyopathy: bad news for the dystrophin-glycoprotein complex.
  Journal
Herz 25:227-32 (2000)
DOI:10.1007/s000590050011
Reference
  Authors
Knowlton KU
  Title
CVB infection and mechanisms of viral cardiomyopathy.
  Journal
Curr Top Microbiol Immunol 323:315-35 (2008)
DOI:10.1007/978-3-540-75546-3_15
Reference
  Authors
Castellano G, Affuso F, Di Conza P, Fazio S
  Title
Myocarditis and dilated cardiomyopathy: possible connections and treatments.
  Journal
J Cardiovasc Med (Hagerstown) 9:666-71 (2008)
DOI:10.2459/JCM.0b013e3282f3e9c2
Reference
  Authors
Cooper LT Jr
  Title
Myocarditis.
  Journal
N Engl J Med 360:1526-38 (2009)
DOI:10.1056/NEJMra0800028
Reference
  Authors
Kawai C
  Title
From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future.
  Journal
Circulation 99:1091-100 (1999)
DOI:10.1161/01.CIR.99.8.1091
Reference
  Authors
Liu PP, Mason JW
  Title
Advances in the understanding of myocarditis.
  Journal
Circulation 104:1076-82 (2001)
DOI:10.1161/hc3401.095198
Reference
  Authors
Mason JW
  Title
Myocarditis and dilated cardiomyopathy: an inflammatory link.
  Journal
Cardiovasc Res 60:5-10 (2003)
DOI:10.1016/S0008-6363(03)00437-1
Reference
  Authors
Tam PE
  Title
Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease.
  Journal
Viral Immunol 19:133-46 (2006)
DOI:10.1089/vim.2006.19.133
Related
pathway
lve03050  Proteasome
lve04110  Cell cycle
lve04210  Apoptosis
lve04260  Cardiac muscle contraction
lve04512  ECM-receptor interaction
lve04612  Antigen processing and presentation
lve04660  T cell receptor signaling pathway
lve05414  Dilated cardiomyopathy
KO pathway
ko05416   

DBGET integrated database retrieval system